Central monitoring of depression and anxiety symptoms reduces placebo responses in depression clinical trials: A post hoc exploratory analysis of data from the phase III CCT-004 trial of vortioxetine

Yoshinori Watanabe, Akira Nishimura, Toshiaki Kikuchi, Norifusa Sawada, Manami Imazaki, Isao Inada, Koichiro Watanabe

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Central monitoring of depression and anxiety symptoms reduces placebo responses in depression clinical trials: A post hoc exploratory analysis of data from the phase III CCT-004 trial of vortioxetine'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences